CRMD PEER ANALYSIS

CorMedix Inc — metric-by-metric comparison with peers and the industry median

CRMDCorMedix Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

CRMDIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	CRMD	MSB	TLX	RTALB	CSL	Ind. Median
P/E	4.52●	—	—	4.89	30.02	17.81
P/B	1.87	—	6.56	0.61●	2.24	3.49
EV/EBITDA	3.69●	—	123.31	74.61	10.37	14.92
P/S	2.04●	31.91	3.34	6.67	2.67	10.89

Financial Health
Metric	CRMD	MSB	TLX	RTALB	CSL	Ind. Median
Current Ratio	2.98●	—	1.43	1.21	2.57	5.90
Debt/Equity	33.2%	—	112.3%	1.2%●	67.4%	10.9%
NetDebt/EBITDA	-0.16●	—	13.13	0.90	2.22	1.15

Profitability
Metric	CRMD	MSB	TLX	RTALB	CSL	Ind. Median
Net Margin	45.2%	-115.3%	-0.9%	136.3%●	9.2%	-125.7%
ROE	65.6%●	-11.3%	-1.8%	15.1%	7.7%	-47.5%
ROA	37.5%●	-8.6%	-0.7%	13.1%	3.8%	-35.8%
EBITDA Margin	53.2%●	-76.6%	3.0%	9.0%	32.8%	-105.8%

Growth + Dividend
Metric	CRMD	MSB	TLX	RTALB	CSL	Ind. Median
Rev. Growth	384.6%	410.4%●	56.3%	24.0%	4.8%	5.1%
NI Growth	953.6%●	—	—	134.0%	-39.4%	12.1%
Div. Yield	—	0.0%	—	0.0%	2.5%●	0.2%
Payout	—	0.0%	—	0.0%	103.1%	0.0%

Valuation
Metric	CRMD	ZVRA	SPRY	TBPH	RIGL	XOMA	Ind. Median
P/E	4.52	—	—	7.61	2.18●	24.24	17.81
P/B	1.87●	4.09	13.49	3.00	1.98	6.77	3.49
EV/EBITDA	3.69●	—	—	3.86	5.27	15.82	14.92
P/S	2.04●	—	8.36	7.94	2.64	21.08	10.89

Financial Health
Metric	CRMD	ZVRA	SPRY	TBPH	RIGL	XOMA	Ind. Median
Current Ratio	2.98	4.89	4.94	13.14●	2.62	3.59	5.90
Debt/Equity	33.2%	0.6%●	157.4%	25.2%	11.4%	110.5%	10.9%
NetDebt/EBITDA	-0.16	—	0.54	-2.26●	-0.77	0.59	1.15

Profitability
Metric	CRMD	ZVRA	SPRY	TBPH	RIGL	XOMA	Ind. Median
Net Margin	45.2%	—	-200.0%	104.3%	121.5%●	87.0%	-125.7%
ROE	65.6%	—	-136.4%	50.2%	174.1%●	31.9%	-47.5%
ROA	37.5%	—	-64.4%	28.1%	107.0%●	13.0%	-35.8%
EBITDA Margin	53.2%	—	-194.1%	129.8%	43.8%	138.4%●	-105.8%

Growth + Dividend
Metric	CRMD	ZVRA	SPRY	TBPH	RIGL	XOMA	Ind. Median
Rev. Growth	384.6%●	—	1.9%	68.2%	47.6%	-3.3%	5.1%
NI Growth	953.6%●	—	—	—	879.7%	—	12.1%
Div. Yield	—	—	—	—	—	0.7%	0.2%
Payout	—	—	—	—	—	17.5%	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on CRMD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.